SOX5

protein-coding

SRY-box transcription factor 5, the group of SRY-box transcription factors

Gene summary

This gene encodes a member of the SOX (SRY-related HMG-box) family of transcription factors involved in the regulation of embryonic development and in the determination of the cell fate. The encoded protein may act as a transcriptional regulator after forming a protein complex with other proteins. The encoded protein may play a role in chondrogenesis. A pseudogene of this gene is located on chromosome 8. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]

MANE transcript

NM_006940.6

Inheritance

AD

ClinVar variants

P:93U:179B:52

Top phenotype

Lamb-Shaffer syndrome

gnomAD constraint

pLI —, LoF o/e 0.07

Max pathogenic AF

—

Genomic locus

chr12:23,529,504-24,562,544

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~1,033.0 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

Lamb-Shaffer syndromeDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0014778

Submitter: ClinGen

*SOX5* variants were first reported in relation to autosomal dominant Lamb-Shaffer syndrome in 2012 (Lamb et al., PMID:22290657). *SOX5* encodes a SRY-related HMG-box transcription factor involved in the regulation of embryonic development, chondrogenesis, and nervous system development. Lamb-Shaffer syndrome is characterized by developmental delay/intellectual disability, autism spectrum disorder, hypotonia, skeletal defects, dysmorphic facial features including frontal bossing, facial asymmetry, strabismus, depressed nasal bridge, bulbous nasal tip and crowded teeth. At least 10 unique heterozygous variants (large deletions, translocations, truncating and missense) have been reported in 10 probands in 5 publications (PMIDs:22290657, 29477873, 31578471, 33296143, 234938568) included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. Two subjects from Lamb et al (PMID:22290657) and one from Lee et al (PMID:23498568) included in the curation were unable to be entered for scoring due the limitations of the gene curation interface. Details of these subjects are as follows: Lamb et al reported Subject 2, a 4 year old female with a 137 kb de novo intragenic *SOX5* deletion and global developmental delay (2 points) and Subject 6, a 4 year old male with a 133 kb intragenic *SOX5* deletion and global developmental delay, strabismus, and frontal bossing (1.5 points). These variants were identified via oligonucleotide-based aCGH. Lee et al reported a 32 month-old male with a 53 kb de novo *SOX5* deletion identified by chromosomal microarray and intellectual disability, speech delay and frontal bossing (2 points). Inclusion of these three individuals contributed 5.5 points to this curation. This gene-disease relationship is also supported by experimental evidence. Dy et al (PMID:18543318) generated a conditional null mouse model that demonstrated generalized chrondrodysplasia. The skeletal defects present in this model are similar to those observed in individuals with Lamb-Shaffer syndrome. Due to a lack of a neurodevelopmental phenotype in this model, the score has been downgraded. In summary, *SOX5* is definitively associated with autosomal dominant Lamb-Shaffer syndrome. This classification was approved by the Intellectual Disability and Autism Gene Curation Expert Panel on 01/27/2022 (SOP version 8).

Lamb-Shaffer syndromeSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0014778

Submitter: G2P

developmental and speech delay due to SOX5 deficiencySUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0017782

Submitter: Orphanet

Lamb-Shaffer syndromeSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0014778

Submitter: PanelApp Australia

Lamb-Shaffer syndromeSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0014778

Submitter: Labcorp Genetics (formerly Invitae)

Clinical Genomic Database (CGD)

Lamb-Shaffer syndromeAD

Manifestation: Craniofacial; Musculoskeletal; Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 22290657; 23220431; 23498568; 26111154Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to SOX5 variants in ClinVar

21 Conditions Cataloged
not providedTotal: 146
Lamb-Shaffer syndromeTotal: 108
Inborn genetic diseasesTotal: 85
SOX5-related disorderTotal: 31
not specifiedTotal: 20
Intellectual disabilityTotal: 5
Generalized hypotoniaTotal: 2
Epileptic encephalopathyTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_006940.6. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
26
clinvar
4
clinvar
32
missense
5
clinvar
21
clinvar
171
clinvar
21
clinvar
218
nonsense
16
clinvar
10
clinvar
26
start loss
1
clinvar
1
frameshift
17
clinvar
8
clinvar
2
clinvar
27
splice donor/acceptor (+/-2bp)
10
clinvar
6
clinvar
3
clinvar
1
clinvar
20
Total4845179484324

Highest pathogenic variant AF is 0.000006573585

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 70 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_006940.6RefSeqNP_008871.315MANE Select
ENST00000451604.7EnsemblENSP00000398273.215MANE Select
NM_001261414.3RefSeqNP_001248343.112Standard
NM_001261415.3RefSeqNP_001248344.115Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Neural Crest Differentiation
  • Endochondral Ossification

Biological Process

  • transcription by RNA polymerase II
  • positive regulation of chondrocyte differentiation
  • cell fate commitment
  • negative regulation of transcription, DNA-templated
  • positive regulation of transcription by RNA polymerase II

Molecular Function

  • DNA-binding transcription factor activity, RNA polymerase II-specific
  • DNA binding
  • DNA-binding transcription factor activity
  • protein binding

Cellular Component

  • nucleus

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000451604
Coding exons
15
Length
421527
Individuals with no LoFs
125741
Homozygous LoFs
0
Heterozygous LoFs
4
Defined
125745
p
0.0000159
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense3.152444270.5710.00002325018
Missense (PolyPhen)77214.810.358452495
Synonymous-0.2101591561.020.000008521478
Loss of Function5.52341.20.07280.00000215458

Population LoF Frequency

PopulationCAFp-valueStatus
African0.0000620.000062rare
Latino/Admixed American00.0absent
Ashkenazi Jewish0.0000990.000099rare
East Asian0.0000540.000054rare
Finnish00.0absent
European (Non-Finnish)0.00000880.0000088rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Binds specifically to the DNA sequence 5'-AACAAT-3'. Activates transcription of COL2A1 and AGC1 in vitro.;
Disease
DISEASE: Lamb-Shaffer syndrome (LAMSHF) [MIM:616803]: An autosomal dominant, neurodevelopmental disorder characterized by global developmental delay, intellectual disability, language and motor impairment, and distinct facial features. Additional variable skeletal abnormalities may also be present. {ECO:0000269|PubMed:22290657, ECO:0000269|PubMed:23220431, ECO:0000269|PubMed:23498568, ECO:0000269|PubMed:26111154}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.178

Intolerance Scores

LoFtool
0.0509
RVIS EVS
-0.96
RVIS percentile EVS
9.09

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.804

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.